[go: up one dir, main page]

MX2010001636A - Derivados de pirazolo[3,4-d]-pirimidina como agentes antiproliferativos. - Google Patents

Derivados de pirazolo[3,4-d]-pirimidina como agentes antiproliferativos.

Info

Publication number
MX2010001636A
MX2010001636A MX2010001636A MX2010001636A MX2010001636A MX 2010001636 A MX2010001636 A MX 2010001636A MX 2010001636 A MX2010001636 A MX 2010001636A MX 2010001636 A MX2010001636 A MX 2010001636A MX 2010001636 A MX2010001636 A MX 2010001636A
Authority
MX
Mexico
Prior art keywords
diazo bicyclic
smac mimetics
mimetics
bicyclic smac
relates
Prior art date
Application number
MX2010001636A
Other languages
English (en)
Inventor
David Joseph Bartkovitz
Xin-Jie Chu
Kin-Chun Thomas Luk
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Priority claimed from PCT/US2008/060215 external-priority patent/WO2008128171A2/en
Publication of MX2010001636A publication Critical patent/MX2010001636A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención está dirigida a derivados de pirazolo[3,4-d]pirimidina novedosos de fórmula (I), y sales y ésteres farmacéuticamente aceptables de los mismos, donde R, el Anillo A, L y el anillo B son como se describe aquí. Esos compuestos y sus sales y ésteres farmacéuticamente aceptables inhiben la Raf cinasa y tienen actividad antiproliferativa. Por lo tanto, son útiles en el tratamiento o control de trastornos proliferativos como el cáncer, en particular tumores sólidos, de manera más particular tumor de mama, tumor de colón, tumor de pulmón, tumor de próstata y melanoma. También se describe una composición y una formulación de dosis unitaria que comprende ese compuesto, o una sal o éster farmacéuticamente aceptable del mismo para producir esos compuestos, y métodos para usar esos compuestos, o sus sales o ésteres farmacéuticamente aceptables, en el tratamiento de trastornos proliferativos. (Ver fórmula I).
MX2010001636A 2007-08-14 2008-04-14 Derivados de pirazolo[3,4-d]-pirimidina como agentes antiproliferativos. MX2010001636A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95565307P 2007-08-14 2007-08-14
PCT/US2008/060215 WO2008128171A2 (en) 2007-04-13 2008-04-14 Diazo bicyclic smac mimetics and the uses thereof

Publications (1)

Publication Number Publication Date
MX2010001636A true MX2010001636A (es) 2010-03-15

Family

ID=39760502

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010001636A MX2010001636A (es) 2007-08-14 2008-04-14 Derivados de pirazolo[3,4-d]-pirimidina como agentes antiproliferativos.

Country Status (12)

Country Link
US (1) US7968554B2 (es)
EP (1) EP2188290B1 (es)
JP (1) JP5296790B2 (es)
KR (1) KR20100038431A (es)
CN (1) CN101965349B (es)
AT (1) ATE512152T1 (es)
AU (1) AU2008288538A1 (es)
BR (1) BRPI0815334A2 (es)
CA (1) CA2694666C (es)
ES (1) ES2366268T3 (es)
MX (1) MX2010001636A (es)
WO (1) WO2009021869A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9408885B2 (en) 2011-12-01 2016-08-09 Vib Vzw Combinations of therapeutic agents for treating melanoma
EP3579872A1 (en) 2017-02-10 2019-12-18 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of cancers associated with activation of the mapk pathway
WO2019133810A1 (en) 2017-12-28 2019-07-04 Tract Pharmaceuticals, Inc. Stem cell culture systems for columnar epithelial stem cells, and uses related thereto
SG11202110547YA (en) * 2019-04-10 2021-10-28 Cellestia Biotech Ag Compounds for the treatment of oncovirus induced cancer and methods of use thereof

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2732970B1 (fr) 1995-04-14 1997-05-16 Hoechst Schering Agrevo Sa Nouveaux derives de l'acide beta-methoxy acrylique, leur procede de preparation et leur application comme pesticides
US6232320B1 (en) * 1998-06-04 2001-05-15 Abbott Laboratories Cell adhesion-inhibiting antiinflammatory compounds
UA60365C2 (uk) 1998-06-04 2003-10-15 Пфайзер Продактс Інк. Похідні ізотіазолу, спосіб їх одержання, фармацевтична композиція та спосіб лікування гіперпроліферативного захворювання у ссавця
DK1140938T3 (da) 1999-01-11 2003-12-22 Univ Princeton Højaffinitetsinhibitorer for målvalidering og anvendelser heraf
HN2000000051A (es) 1999-05-19 2001-02-02 Pfizer Prod Inc Derivados heterociclicos utiles como agentes anticancerosos
JP2004514714A (ja) 2000-11-28 2004-05-20 ファイザー・プロダクツ・インク イソチアゾール−4−カルボキサミドの塩及びそれらの抗増殖過剰剤としての使用
EA007987B1 (ru) 2002-03-29 2007-02-27 Чирон Корпорейшн Замещённые бензазолы и их применение в качестве ингибиторов киназы raf
EP1556053A4 (en) * 2002-10-31 2006-04-19 Amgen Inc ANTI-INFLAMMATORY AGENTS
JP2006528685A (ja) 2003-05-06 2006-12-21 スミスクライン ビーチャム コーポレーション 新規化合物
US20050020619A1 (en) * 2003-07-24 2005-01-27 Patrick Betschmann Thienopyridine kinase inhibitors
US20050026944A1 (en) * 2003-07-24 2005-02-03 Patrick Betschmann Thienopyridine and furopyridine kinase inhibitors
US7202363B2 (en) * 2003-07-24 2007-04-10 Abbott Laboratories Thienopyridine and furopyridine kinase inhibitors
KR20070029643A (ko) 2003-12-05 2007-03-14 베링거 인겔하임 파마슈티칼즈, 인코포레이티드 IKK 억제제로서의 치환된3-아미노-티에노[2,3-b]피리딘-2-카복실산 아미드 화합물
US20060025383A1 (en) * 2004-02-03 2006-02-02 Neil Wishart Aminobenzoxazoles as therapeutic agents
US20050256154A1 (en) * 2004-05-04 2005-11-17 Kin-Chun Luk 4-Amino-thieno[3,2-c]pyridine-7-carboxylic acid amides
US7405220B2 (en) 2004-06-09 2008-07-29 Hoffmann-La Roche Inc. Pyrazolopyrimidines
EP1831225A2 (en) 2004-11-19 2007-09-12 The Regents of the University of California Anti-inflammatory pyrazolopyrimidines
WO2006125101A2 (en) 2005-05-20 2006-11-23 Array Biopharma Inc. Raf inhibitor compounds and methods of use thereof
NZ565255A (en) * 2005-06-22 2010-04-30 Plexxikon Inc Pyrrolo[2,3-b] pyridine derivatives as protein kinase inhibitors
AR057455A1 (es) * 2005-07-22 2007-12-05 Merck & Co Inc Inhibidores de la transcriptasa reversa de vih y composicion farmaceutica
EP1926737B1 (en) * 2005-09-15 2017-03-15 F. Hoffmann-La Roche AG 4-amino-thieno[3,2-c]pyridine-7-carboxylic acid derivatives
CN101336244B (zh) * 2005-12-08 2011-11-30 雅培制药有限公司 用作蛋白激酶抑制剂的9元杂二环化合物
WO2007075554A2 (en) 2005-12-19 2007-07-05 Osi Pharmaceuticals, Inc. Combination of igfr inhibitor and anti-cancer agent

Also Published As

Publication number Publication date
JP2010535835A (ja) 2010-11-25
CN101965349B (zh) 2016-05-04
CA2694666C (en) 2015-07-14
BRPI0815334A2 (pt) 2019-09-24
US7968554B2 (en) 2011-06-28
ATE512152T1 (de) 2011-06-15
EP2188290B1 (en) 2011-06-08
AU2008288538A1 (en) 2009-02-19
CN101965349A (zh) 2011-02-02
JP5296790B2 (ja) 2013-09-25
CA2694666A1 (en) 2009-02-19
WO2009021869A1 (en) 2009-02-19
KR20100038431A (ko) 2010-04-14
EP2188290A1 (en) 2010-05-26
ES2366268T3 (es) 2011-10-18
US20090048274A1 (en) 2009-02-19

Similar Documents

Publication Publication Date Title
MX2009011069A (es) Mimeticos de smac diazo biciclicos y usos de los mismos.
WO2007130626A3 (en) Bivalent smac mimetics and the uses thereof
WO2005069888A3 (en) Smac peptidomimetics and the uses thereof
WO2009126947A3 (en) Heteroaryl-substituted bicyclic smac mimetics and the uses thereof
WO2005069894A3 (en) Conformationally constrained smac mimetics and the uses thereof
WO2006010118A3 (en) Conformationally constrained smac mimetics and the uses thereof
TN2012000485A1 (en) Predictive markers useful in the treatment of fragile x syndrome (fxs)
WO2011050068A3 (en) Bivalent diazo bicyclic smac mimetics and the uses thereof
HN2009000214A (es) Peptidomimeticos de smac utiles como inhibidores de proteinas de apoptosis (iap)
ECSP066893A (es) Inhibidores de proteínas de apoptosis (iap)
CL2012002904A1 (es) Combinación o composición farmacéutica que comprende un inhibidor de la señalización de células y/o de la angiogénesis y un inhibidor de la quinasa aurora (aki); kit faramcéutico que la comprende; su uso en el tratamiento de enfermedades oncológicas y fibróticas; y compuestos derivados de indol y pirimidina sustituidos.
EP2044956A4 (en) MEANS FOR PROMOTING THE PROLIFERATION OF HEMATOPOETIC STEM CELLS
SMT201600003B (it) Inibitori indazolici della via di segnalazione wnt e loro usi terapeutici
CL2010001637A1 (es) Compuestos derivados de isoindolonas; composición farmacéutica que los comprende; y su uso como inhibidores de la quinasa mek para tratar enfermedades hiperproliferativas y/o inflamatorias tales como cáncer, artritis reumatoidea entre otras.
EA201270553A1 (ru) Ингибиторы тирозинкиназы брутона
BR112012000934A2 (pt) cassetes e métodos de utilizacao destes
ECSP13012394A (es) Nuevas formas de dosificación de liberación modificada de un inhibidor de la xantina oxidorreductasa o de inhibidores de xantina oxidasa
WO2012065139A3 (en) Entpd5 inhibitors
MY176901A (en) Gla domains as targeting agents
EA200601562A1 (ru) Сокристаллы госсипола и их применение
MX2013007835A (es) Combinacion de sirosingopina e inhibidores mitocondriales para el tratamiento de cancer e inmunosupresion.
CR20130190A (es) Inhibidores de apoptosis y usos de los mismos
WO2006050447A3 (en) Apogossypolone and the uses thereof
MX2010001636A (es) Derivados de pirazolo[3,4-d]-pirimidina como agentes antiproliferativos.
MA32474B1 (fr) Nouveaux derives de (piperazinyl ponte) -1-alcanone et leur utilisation comme inhibiteurs de p75

Legal Events

Date Code Title Description
FA Abandonment or withdrawal